TMC114-TiDP3-C176 - A Study in Healthy Volunteers Investigating the Bioequivalence Between Two Commercially Available 400-mg Tablets to One New 800-mg Tablet of Darunavir (DRV) in the Presence of Low-dose Ritonavir Under Fed and Fasted Conditions

Name: TMC114-TiDP3-C176 - A Study in Healthy Volunteers Investigating the Bioequivalence Between Two Commercially Available 400-mg Tablets to One New 800-mg Tablet of Darunavir (DRV) in the Presence of Low-dose Ritonavir Under Fed and Fasted Conditions
Published: 2011
License: Public Domain

Tibotec Pharmaceuticals, Ireland · 2011

ClinicalTrials.gov · Datasets · License: Public Domain · 2011

Open Source ↗

healthy hiv

healthy, tmc114-c176, tmc114, drv, hiv, healthy volunteers, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

TMC114-TiDP3-C176 - A Study in Healthy Volunteers Investigating the Bioequivalence Between Two Commercially Available 400-mg Tablets to One New 800-mg Tablet of Darunavir (DRV) in the Presence of Low-dose Ritonavir Under Fed and Fasted Conditions

Related documents